USDJPY keeps dancing near its recent weekly peaks (158.00). Although the Bank of Japan (BoJ) continues to tighten monetary conditions, the country’s fundamental economic problems remain very much acute, weighing on the national currency.
The yen’s key struggle is the same old sticky inflation, which only keeps rising. In September, Tokyo’s Core Consumer Price Index (CPI) accelerated to 2.4%, jumping above the BoJ’s target level. A weaker national currency and elevated energy prices make imported goods more expensive, eroding the purchasing power of the population. Further policy tightening may continue to slow Gross Domestic Product (GDP) growth.
Japan’s heavy debt burden also bothers investors. According to the International Monetary Fund (IMF), the country’s public liabilities will stand at approximately 203% of GDP in 2026—one of the highest levels among developed economies. Rising bond yields increase new borrowing costs for the government and put additional strain on the budget. So, the BoJ appears caught between a rock and a hard place. On the one hand, stubborn inflation calls for rate hikes; on the other—officials have to avoid an excessive rise in the cost of servicing the national debt.
The monetary divergence between the Federal Reserve (Fed) and the BoJ is still significant. This also weighs on the yen. Despite the Asian regulator’s rate hike to 1.25%, it remains far below the American range of 3.75%–4.00%, continuing to boost the appeal of dollar‑denominated assets.
At the same time, the primary risk to further gains in USDJPY is the high probability of new currency interventions. Japanese authorities have already stepped into the FX market multiple times to underpin the yen. Thus, as the exchange rate approaches the psychologically important 160.00 level, such actions could be triggered once again.
The overall recommendation is to sell USDJPY at the current price of 158.00, targeting 152.00 within a month. To mitigate the risk of adverse market movements, place a Stop Loss order at 160.50.
This content is for informational purposes only and is not intended to be investing advice.
